treatment procedure, Dr Thiagarajan Srinivasan saidThe patient brother donated a part of his liver

Explaining the treatment procedure, Dr Thiagarajan Srinivasan said, “The patient’s brother donated a part of his liver after ascertaining the absence of genetic disease. Before and after surgery, the patient underwent multiple courses of monoclonal antibody therapy(Eculuzimab) to keep the clotting and hemolysis at bay. A combined living donor liver transplant with replacement of the inferior vena cava with a synthetic Dacron graft* was done. He added that it has been four months since the procedure and the patient was doing well. The team of doctors are planning a bone marrow transplant to cure his genetic illness. To our knowledge this is the first time in the country such a complex course of treatment with liver transplant has happened for such a complicated rare genetic disorder with liver failure.” The patient was suffering from a rarest-of-rare fatal, sharing his thoughts, Dr. Karthik Mathivanan said, “Genetic condition which was leading to end stage liver failure, the patient needed a liver